• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GERN:GR

1.762 EUR 0.029 1.62%

As of 08:19:25 ET on 08/01/2014.

Snapshot for Geron Corp (GERN)

Open: 1.781 Day's Range: 1.762 - 1.822 Volume: 261
Previous Close: 1.791 52wk Range: 0.876 - 5.093 1-Yr Rtn: +72.35%

Stock Chart for GERN

No chart data available.
  • GERN:GR 1.762
  • 1D
  • 1M
  • 1Y
1.791
Interactive GERN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GERN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2480
Est. PEG Ratio -
Market Cap (M EUR) 276.53
Shares Outstanding (M) 156.94
30 Day Average Volume 2,410
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GERN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GERN

Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

John A ScarlettPresident/CEOOlivia K BloomExec VP:Finance/CFO/Treasurer
Stephen N RosenfieldExec VP/General Counsel/SecyAndrew J Grethlein "Andy"Exec VP:Tech Operations
More Company Profile & Key Executives for GERN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil